For months the British public have been deceived with tales that there are just 5 million people in the United Kingdom who have refused to take up the offer of a Covid-19 vaccine. But today we can reveal that this is a lie.
It is a complete fabrication that has no doubt been used to make those who have refused the jab feel as if they are part of a minority, because an official UK Government report proves that in England alone there are approximately 23.5 million people who have not had a single dose of a Covid-19 vaccine.
GlaxoSmithKline
Browse the articles related to this topic below.
Join our community on Guilded.
Whitney Webb is interviewed by the Investigative Corona Committee Germany about who is influencing the conversation around COVID-19. Her interview starts at 1h09m.
Interview notes:
- Google Ventures’ investment in the AstraZeneca vaccine via Vaccitech.
- Reworking of the healthcare system and replacement of doctors with artificial intelligence.
- The ties between government, Big Tech, the military, healthcare and artificial intelligence.
- The AstraZeneca-Oxford vaccine is not non-profit. The two developers at the Jenner Institute, Sarah Gilbert and Adrian Hill, have a company, Vaccitech, on which the technology is based.
- The British Government has directly invested in Vaccitech and is expected a profit.
- The other main stakeholder is Bravos Capital (through Oxford Science Innovation), which was set up by former head of Global Equity Trading at Deutsche Bank.
- The German Government has invested money in CureVac BioNTech vaccine. 20% of the shares is owned by the German Government.
- Sequoia Capital‘s Chinese Branch, Fosun Pharma and The Wellcome Trust (through Oxford Science Innovation) are also investors in Vaccitech.
- The Wellcome Trust is the institution that is most involved in the AstraZeneca vaccine.
- The Jenner Institute is conducting trials in Africa for a universal malaria vaccine and they have a nasty track-record of not being honest about their trials. They lied about risks and infants died.
- The Jenner Institute was a public-private partnership with GlaxoSmithKline and the UK Government in the 1990s. They are one of the main vehicles at Oxford University for vaccine development and also UK vaccine funding research.
- Adrian Hill, the head of the Jenner Institute, is the chief at the UK Government’s UK Vaccine Network which decides which technology to research, fund and give to the population both in the UK and globally through vaccine philanthropy.
- COVAX, The Bill & Melinda Gates Foundation effort to vaccinate the developing world, relies almost entirely on AstraZeneca.
- Johnson & Johnson is being manufactured by Emergent BioSolutions which previously was called BioPort.
- BioPort was a spin-off of a fusion between Porton Down, the UK’s bio-defence lab (Defence Science and Technology Laboratory), and the between [William_J._Crowe] the former head of the Joint Chiefs of Staff under US President Ronald Regan.
- Emergent BioSolutions/BioPort was chosen to manufacture the Johnson & Johnson vaccine despite many scandals.
- The person in-charge of quality control for the Johnson & Johnson vaccine has no experience in the field. His background is head of Military Intelligence teams for the US Military in Iraq and Afghanistan and is also an expert on Iran and North Korea.
- Emergent BioSolutions are intimately connected to the CIA and Bechtel Corporation which has ties to the anthrax attacks in the US.
- Dr. Wodarg raised the possibility that the current situation is being used to covertly study wide use mRNA vaccines.
- Pfizer and Moderna mRNA technology was started with significant investment from DARPA in 2013.
- In 2016, Moderna was the most highly valued biotech company in the US but had no products.
- Regina Dugan greenlighted the investments from DARPA and later left in 2012 to create a DARPA-equivalent for Google and Facebook. She has now teamed up with the Wellcome Trust to create a ‘global health DARPA-equivalent’.
- Some discussion on the pre-911 anthrax vaccine and anthrax attack scandal, with links to reporter Judith Miller who was later involved in the Dark Winter simulation in June 2001.
- A lot of the same people who produced the Dark Winter simulation are the same people who oversaw Event 201 simulation.
- Dr. Wodarg raised concerns about the experimentation with lipid nanoparticles.
- There is a clear push to ‘remake healthcare’ from Silicon Valley towards AI healthcare and Precision Medicine, which is medications, vaccines and gene therapy targeted to the individual.
- A lot of COVID-19 testing in the Western US has been done by Google subsidiary Verily Life Sciences.
- AI healthcare and Precision Medicine is being co-developed by Google and the US military’s Defense Innovation Unit.
- Dr. Wodarg observed that we are seeing the unveiling of a long developed strategy.
- The push in medicine for gene editing goes back to Julian Huxley, first Director General of UNESCO and former president of the British Eugenics Society (renamed in 1989 to the Galton Institute). Julian Huxley, brother of Aldous Huxley, said in 1946 that we should, “make the unthinkable thinkable again” and also coined the term Transumanism. He said that gene editing as a eugenics science needed to be applied along with efforts to merge humans with machines in order to create a ‘new human being’. This goes back to 1957.
- Adrian Hill of the AstraZeneca vaccine spoke at the Galton Institute’s 100 Year Anniversary. The Wellcome Trust hosts their archive.
- Julian Huxley’s speech about “making the unthinkable thinkable again” was in connection with the founding of UNESCO.
- The push for Precision Medicine is ultimately about control and eugenics.
- The Obama Administration funded a lot of the Precision Medicine initiatives. The Biden Administration is creating a ‘health DARPA’ which will be led by Eric Lander (who has ties with Jeffrey Epstein).
- Jeffrey Epstein wanted the seed the human race with his own DNA. The scientists Epstein funded are still around. One of them is Harvard genetecist George Church who has openly promoted unethical human experimentation and eugenics.
- The Edge Foundation was operating as a front for Epstein as a way to gain influence in Silicon Valley, science and academia. His main handler is probably the Mega Group. He has ties with Isabelle Maxwell (Gislane Maxwell’s sister) who is a World Economic Forum technology pioneer.
- Bill Gates‘ ties with Epstein looks to go back to the 1990s. A 2001 Evening Standard article claims that Epstein’s main business partners were Leslie Wexner, Donald Trump and Bill Gates. Microsoft as a company may have been compromised by the same intelligence networks that Epstein operated in.
- Yuval Noah Harari: soon there will be an age of digital dictators and humans have been reduced to ‘hackable animals’ through technology.
- Klaus Schwab openly talks about COVID-19 being the catalyst for The Great Reset and Transhumanism. The fear of COVID would give way to the fear of Climate Change and Cyber Pandemic.
Backup mirrors:
THE influence of the Bill & Melinda Gates Foundation (GF) extends right into the heart of the British medical and science establishment. It has been funding British companies, charities, universities and public bodies for almost 25 years.
Wikipedia snapshot from 9 March 2021:
| Year | Company | Settlement | Violation(s) | Product(s) | Laws allegedly violated (if applicable) |
|---|---|---|---|---|---|
| 2012 | GlaxoSmithKline[1][6] | $3 billion ($1B criminal, $2B civil) | Criminal: Off-label promotion, failure to disclose safety data. Civil: paying kickbacks to physicians, making false and misleading statements concerning the safety of Avandia, reporting false best prices and underpaying rebates owed under the Medicaid Drug Rebate Program | Avandia (not providing safety data), Wellbutrin, Paxil (promotion of paediatric use), Advair, Lamictal, Zofran, Imitrex, Lotronex, Flovent, Valtrex | False Claims Act, FDCA |
| 2009 | Pfizer[2] | $2.3 billion | Off-label promotion, kickbacks | Bextra, Geodon, Zyvox, Lyrica | False Claims Act, FDCA |
| 2013 | Johnson & Johnson[7] | $2.2 billion | Off-label promotion, kickbacks | Risperdal, Invega, Nesiritide | False Claims Act, FDCA |
| 2012 | Abbott Laboratories[8] | $1.5 billion | Off-label promotion | Depakote | False Claims Act, FDCA |
| 2009 | Eli Lilly[9] | $1.4 billion | Off-label promotion | Zyprexa | False Claims Act, FDCA |
| 2001 | TAP Pharmaceutical Products[10] | $875 million | Medicare fraud, kickbacks | Lupron | False Claims Act, Prescription Drug Marketing Act |
| 2012 | Amgen[11] | $762 million | Off-label promotion, kickbacks | Aranesp | False Claims Act, FDCA |
| 2010 | GlaxoSmithKline[12] | $750 million | Poor manufacturing practices | Kytril, Bactroban, Paxil CR, Avandamet | False Claims Act, FDCA |
| 2005 | Serono[13] | $704 million | Off-label promotion, kickbacks, monopolistic practices | Serostim | False Claims Act |
| 2008 | Merck[14] | $650 million | Medicare fraud, kickbacks | Zocor, Vioxx, Pepsid | False Claims Act, Medicaid Rebate Statute |
| 2007 | Purdue Pharma[15] | $601 million | Off-label promotion | Oxycontin | False Claims Act |
| 2010 | Allergan[16] | $600 million | Off-label promotion | Botox | False Claims Act, FDCA |
| 2010 | AstraZeneca[17] | $520 million | Off-label promotion, kickbacks | Seroquel | False Claims Act |
| 2007 | Bristol-Myers Squibb[18] | $515 million | Off-label promotion, kickbacks, Medicare fraud | Abilify, Serzone | False Claims Act, FDCA |
| 2002 | Schering-Plough[19] | $500 million | Poor manufacturing practices | Claritin | FDA Current Good Manufacturing Practices |
| 2006 | Mylan[20] | $465 million | Misclassification under the Medicaid Drug Rebate Program | EpiPen (epinephrine) | False Claims Act |
| 2006 | Schering-Plough[21] | $435 million | Off-label promotion, kickbacks, Medicare fraud | Temodar, Intron A, K-Dur, Claritin RediTabs | False Claims Act, FDCA |
| 2004[22] | Pfizer | $430 million | Off-label promotion | Neurontin | False Claims Act, FDCA |
| 2008 | Cephalon[23] | $425 million | Off-label promotion[23] | Actiq, Gabitril, Provigil | False Claims Act, FDCA |
| 2010 | Novartis[24] | $423 million | Off-label promotion, kickbacks | Trileptal | False Claims Act, FDCA |
| 2003 | AstraZeneca[25] | $355 million | Medicare fraud | Zoladex | Prescription Drug Marketing Act |
| 2004 | Schering-Plough[26] | $345 million | Medicare fraud, kickbacks | Claritin | False Claims Act, Anti-Kickback Statute |
Categories
Pharmaceutical fraud – Wikipedia
$3 billion GSK settlement. On 2 July 2012, GlaxoSmithKline pleaded guilty to criminal charges and agreed to a $3 billion settlement of the largest health-care fraud case in the U.S. and the largest payment by a drug company. The settlement is related to the company’s illegal promotion of prescription drugs, its failure to report safety data, bribing doctors, and promoting medicines for uses for which they were not licensed. The drugs involved were Paxil, Wellbutrin, Advair, Lamictal, and Zofran for off-label, non-covered uses. Those and the drugs Imitrex, Lotronex, Flovent, and Valtrex were involved in the kickback scheme. The government investigation of GSK was launched largely on the basis of information provided by four whistleblowers who filed two qui tam (whistleblower) lawsuits against the company under the False Claims Act. GSK settled the whistleblowers’ lawsuits for a total of $1.017 billion out of the $3 billion settlement, the largest civil False Claims Act settlement to date.
Pfizer $2.3 billion settlement: Pfizer settled multiple civil and criminal allegations for $2.3 billion in the largest case of pharmaceutical and health care fraud in US history. The drugs involved were Bextra (an anti-inflammatory drug), Geodon (an anti-psychotic drug), Lipitor (a cholesterol drug), Norvasc (anti-hypertensive drug), Viagra (erectile dysfunction), Zithromax (antibiotic), Zyrtec (antihistamine), Zyvox (an antibiotic), Lyrica (an anti-epileptic drug), Relpax (anti-migraine drug), Celebrex (anti-inflammatory drug), and Depo-provera (birth control).
Merck $650 million settlement: Merck settled a nominal pricing fraud case in which the company was accused of taking kickbacks and violating Medicaid best price regulations for various drugs.
United States et al., ex rel. Jim Conrad and Constance Conrad v. Forest Pharmaceuticals, Inc, et al. involved a drug manufacturer selling a drug, Levothroid, that had never been approved by the FDA. These allegations settled for $42.5 million due to multiple whistleblowers stepping forward to provide detailed information on the alleged fraud. The collective reward to the relators in this case was over $14.6 million.
Wikipedia snapshot from 28 January 2021:
“We fully support the swine flu vaccination programme … The vaccine has been thoroughly tested,” they declared in a joint statement.
Except, it hadn’t. Anticipating a severe influenza pandemic, governments around the world had made various logistical and legal arrangements to shorten the time between recognition of a pandemic virus and the production of a vaccine and administration of that vaccine in the population. In Europe, one element of those plans was an agreement to grant licences to pandemic vaccines based on data from pre-pandemic “mock-up” vaccines produced using a different virus (H5N1 influenza). Another element, adopted by countries such as Canada, the US, UK, France, and Germany, was to provide vaccine manufacturers indemnity from liability for wrongdoing, thereby reducing the risk of a lawsuit stemming from vaccine related injury.
https://web.archive.org/web/20200408051329/https://www.bmj.com/content/362/bmj.k3948
The UK’s chief scientific adviser has a £600,000 shareholding in a drugs giant contracted to develop a Covid-19 vaccine for the Government, prompting claims of a potential conflict of interest.
- Sir Patrick Vallance, Chief Scientific Adviser to UK Government, was president of GSK 2012 – 2018
- Holds a deferred bonus of 43,111 shares worth £600,000
- Cashed in more than £5m worth of shares upon resignation of GSK
- Sir Vallance special board on vaccines
Council of Europe to discuss whether pharmaceutical firms spread alarm over pandemic to boost orders of medicines
European health chiefs are to hold emergency talks about whether pharmaceutical giants have unduly influenced governments into squandering public money on vast stockpiles of unnecessary swine flu drugs.
Dozens of British children who developed narcolepsy as a result of a swine flu vaccine could be compensated after the high court rejected a government appeal to withhold payments.
Six million people in Britain, and more across Europe, were given the Pandemrix vaccine made by GlaxoSmithKline during the 2009-10 swine flu pandemic, but the jab was withdrawn after doctors noticed a sharp rise in narcolepsy among those who received it.